The long-term effect of increasing MFN2 expression on tumor transformative potential, absent of a concurrent apoptosis-inducing treatment, was not studied in this present work, but remains an interesting prospect for glioblastoma therapy. This evidence concerns the gene MFN2 and glioblastoma.